Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review
about
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsStrategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infectionsSystematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesAntibiotic-free selection in biotherapeutics: now and foreverGenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsIntegration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisPredicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutationsRapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysisComparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from RussiaProgrammatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South AfricaGenetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic reviewFrequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic reviewHigh frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisDetection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon SequencingPrevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.Performance of TaqMan array card to detect TB drug resistance on direct specimens.eis Promoter C14G and C15G Mutations Do Not Confer Kanamycin Resistance in Mycobacterium tuberculosis.Platinum: a database of experimentally measured effects of mutations on structurally defined protein-ligand complexes.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaMolecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.The antituberculosis antibiotic capreomycin inhibits protein synthesis by disrupting interaction between ribosomal proteins L12 and L10.Performance of the MTBDRsl assay in Georgia.A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.Molecular longitudinal tracking of Mycobacterium abscessus spp. during chronic infection of the human lungDetection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesDisparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin NClinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases.Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter StudyPrevalence of Tuberculosis, Drug Susceptibility Testing, and Genotyping of Mycobacterial Isolates from Pulmonary Tuberculosis Patients in Dessie, EthiopiaShedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.Cosubstrate tolerance of the aminoglycoside resistance enzyme Eis from Mycobacterium tuberculosisPerformance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in IndiaMechanisms of Resistance to Aminoglycoside Antibiotics: Overview and PerspectivesUnexpected N-acetylation of capreomycin by mycobacterial Eis enzymes.Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
P2860
Q24193002-5E5ED784-AF07-41A4-B5DC-A23AED52F9A2Q26859978-825DD1DB-BC60-4E40-AE92-9B6380D2E05CQ27004697-9101159F-CFE9-464A-AB7C-BF99DB86A2C5Q27028105-091D2001-62E0-4104-9F58-15B7B7CA3B41Q28068545-617E5287-3590-4962-B2F2-6DC176C1B1BFQ28087770-BC3797A6-66B6-4EBB-AFEA-E594320B09D9Q28397752-FFBFD3CC-7D30-4840-B962-15E225D4B97BQ28485912-CDCA3D3B-0A1A-4DC1-944F-ACB782A0320EQ28486275-066D51F8-2330-4854-BA81-A1E19E4F976DQ28535594-F97EF5CF-57C6-49E0-B1B1-4F912B93C7DFQ28544877-F927C71B-538F-4753-9542-FF088EF3091AQ28545095-B02FDC4D-3B63-4715-90A1-DE12ACB0933CQ28546682-2EF1EB2C-A58A-49B8-9718-B2043FE6BB73Q28547220-672358DF-B7A6-4E42-A53F-04FE0639013DQ30252340-C334C11E-8595-4DE7-AF01-6CFEECA588A4Q30252470-DE80EE27-D5CE-470C-A1A3-C3061E0FA07EQ30275565-04450B22-FA18-4B81-B3D1-04BCA3CA91B4Q30367904-AC179083-30A2-4FF3-8B89-05CDD31C2B57Q33600161-AA669315-9315-486A-BCE5-D45DA873C96CQ33622808-6CCE2F8B-F316-48D6-94A2-D9CB618B9747Q33622886-8CF1B668-B51C-4D3D-8F91-A0A0F81E9F53Q33668222-3D589028-8842-4576-ABB7-4998A27FF7FCQ33812455-5B9BFEDB-61BE-4E48-A4D0-B7577CC5DC30Q33826477-9DF4A097-BAAD-4FC6-B505-0553EED42B64Q34365473-69098A21-C96B-4136-980C-B9363AE05354Q34733713-C27F1A90-5D01-48AE-9475-43F146C2969CQ34738488-0FB467DB-481E-4B7D-B75F-4C581300035AQ34922635-1E12E9E8-BE9C-42ED-AF6E-4BDD941713C2Q34922710-64B95E9F-4668-4DDE-99D5-B3F1985ADD6EQ34924586-6A691947-ADD6-47CC-84E2-00B093578EB6Q35455573-E8C4EDEE-7E4B-42F4-BBE7-D0B2D36142A9Q35693044-2628D894-73EA-49F1-B159-56722935D5F9Q35769140-CCBB8EF9-8F0A-455E-9A4C-EE3B932DC68BQ36117376-F60699A1-A483-4879-A364-DAAB7A9E04E4Q36364084-14A195B9-76A6-4BD6-9859-8547692FDDC1Q36495442-8835ECE8-3C99-49DD-A485-43D6B35D46D0Q36575916-05630750-14B9-4431-996E-57585876D58CQ36675157-886474D5-EEB7-4A22-8461-BFCD2007E10EQ36762984-A33C162A-806C-4978-8374-6A994F2E7AD5Q36869848-D4E6283B-7E3F-4BE6-9FDC-A8A151E07CA1
P2860
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evaluation of genetic mutation ...... preomycin: a systematic review
@ast
Evaluation of genetic mutation ...... preomycin: a systematic review
@en
Evaluation of genetic mutation ...... preomycin: a systematic review
@nl
type
label
Evaluation of genetic mutation ...... preomycin: a systematic review
@ast
Evaluation of genetic mutation ...... preomycin: a systematic review
@en
Evaluation of genetic mutation ...... preomycin: a systematic review
@nl
prefLabel
Evaluation of genetic mutation ...... preomycin: a systematic review
@ast
Evaluation of genetic mutation ...... preomycin: a systematic review
@en
Evaluation of genetic mutation ...... preomycin: a systematic review
@nl
P2093
P2860
P31
P921
P3181
P1433
P1476
Evaluation of genetic mutation ...... preomycin: a systematic review
@en
P2093
Antonino Catanzaro
Marisa Magana
Richard S Garfein
Sophia B Georghiou
Timothy C Rodwell
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0033275
P407
P577
2012-03-29T00:00:00Z